期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

地氯雷他定联合复方甘草酸苷治疗慢性荨麻疹 被引量：1

Therapeutic effect of desloratadine plus compoud glycyrrhizin in treatment of chronic urticaria
下载PDF
导出
摘要 目的观察地氯雷他定联合复方甘草酸苷治疗慢性荨麻疹的疗效。方法将254例慢性荨麻疹患者随机分为两组:地氯雷他定复方甘草酸苷联合治疗组和依巴斯汀对照组。结果治疗组的总有效率高于对照组,两组比较有显著性差异(χ2=12.42,P<0.01);治疗组的不良反应发生率为13.8%,高于对照组的7.3%,但差异无显著性(P<0.05)。结论地氯雷他定联合复方甘草酸苷治疗慢性荨麻疹疗效满意,值得临床选择应用。 OBJECTIVE To observe the efficacy of desloratadine plus compoud glycyrrhizin in the treatment of chronic urticaria.METHODS 254 patients were randomly divided into 2 groups,one（treatment group） with desloratadine plus compoud glycyrrhizin and the other（control group） with ebastine.RESULTS The total effective rates were 89.2% for treatment group and 71.8% for control group（P〈0.01）,significant difference existed.CONCLUSIONS Desloratadine plus compoud glycyrrhizin is effective in treating chronic urticaria,and worth to use in clinical.
作者 杨玉明 梅益萍
机构地区 江苏东台市疾病预防控制中心
出处 《海峡药学》 2008年第10期100-101,共2页 Strait Pharmaceutical Journal
关键词 地氯雷他定 复方甘草酸苷 依巴斯汀 慢性荨麻疹 Desloratadine Compoud glycyrrhizin Ebastine Chronic urticaria
分类号 R969.4 [医药卫生—药理学]
  • 相关文献

参考文献6

  • 1刘辅仁.实用皮肤学[M].第三版.北京:人民卫生出皈社.2004.437.
  • 2Ring J, Hein R, Gauger A. Desloradine in the treatment of chronic idiopathic urticaria[J] .Allegy, 2001, 56(65) :28-32.
  • 3王召昆,张学斌.地氯雷他定治疗三种皮肤病疗效观察[J].皮肤病与性病,2007,29(4):30-31. 被引量：2
  • 4Affrime MB, Banfield C, Glue P, et al.Desloratadine and Ketoconazoie;pharmacokineties and electrocardiographic pharmacodynamic diffects[J]. J Allergy Clin Immunol, 2000, 104 : 386.
  • 5Glue P, Bfield C, Affrime, MB, et al. Desloratadine and erythromythin: pharmacokinetics and electrocardiographic pharmacodynamymie effcts [J]. J Allergy Clin lmmnunol, 2000, 104 : 387.
  • 6郝飞.甘草酸国外研究进展[J].中国药房,2001,12(8):500-501. 被引量：107

二级参考文献10

  • 1[1]Takeda S,Ishthara K, Wakui Y, et al. Bioavailability study ofglycyrrhetic acid after oral administration of glycyrrhizin in rats;relevance to the intestinal bacterial hydrolysis[J].J PharmPharmacol,1996, 48(9):902.
  • 2[2]Van Rossum TG, Vulto AG, De Man RA, et al. Review article:glycyrrhizinas a potential treatment for chron-ic hepatitis C[J].Aliment Pharmacol Ther, 1998, 12(2):199.
  • 3[3]Van Rossum TG, Vulto AG, Hop WC, et al.Intraveno-us glycyrrhizin for the treatment of chronic hepatitis C:a double－blind, randomized, placebo controlled pha-se I/II trial[J]. J Gastroenterol Hepatol,1999, 14(11):1 093.
  • 4[4]Yamamura Y, Kotaki H, Tanaka N, et al. The pharmaco-kinetics of glycyrrhizin and its restorative effect on he-patic function in patients with chronic hepatitis and in chronicallycarbon-tetrachloride-intoxicated rats[J].Biopharm Drug Dispos, 1997, 18(8):717.
  • 5[5]Yamamura Y, Santa T, Kotaki H, et al. Administrationroute dependency of absorption of glycyrrhizin in rat-
  • 6[6]s:intraperitoneal administration dramatically enhancedbioavailability[J]. Biol Pharm Bull, 1995,18(2):337.
  • 7[7]Okamoto T, Tanaka N, Vulto AG, et al. The protectiveeffect of glycyrrhizin on anti-fas antibody-inducedhepatitis in mice[J]. Eur J Pharmacol, 2000, 387(2):229.
  • 8[8]Okamoto T, Kanda T, Vulto AG, et al. Glycyrrhizin protects mice fromconcanavalin A-induced hepatitiswithout affecting cytokine expression[J]. Int J Mol M-ecl, 1999, 4(2):149.
  • 9[9]Tsabota A. Corrbinecl ursodeoxycholic acid and glycyrrhizin therapy forchronic hepatitis C virus infection:a randomized controlled trial in 170patients[J].Eur J Gastroenterd Hepatol, 1999, 11(10):1 077.
  • 10[10]Shiota G, Harada K, Ishida M, et al. Inhibition of hepatocellularcarcinoma by glycyrrhizin in diethylnitrosa-mine-treated mice[J]. Carcinogenesis, 1999,20(1):59.

共引文献107

同被引文献12

引证文献1

二级引证文献7

海峡药学
2008年 第10期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部